| (210) | Number of the EPO application | 17715692 |
| (220) | Filing date of the EPO application | 2017.04.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2020, 2020.11.25 |
| (110) | EPO patent number | 3439672 |
| (11) | Number of the document | MD 3439672 T2 |
| (21) | Number of the application | e 2019 0180 |
| (71) | Name(s) of applicant(s), code of the country | Janssen Vaccines & Prevention B.V., NL; |
| (72) | Name(s) of inventor(s), code of the country | KRARUP Anders, NL;
LANGEDIJK Johannes Petrus Maria, NL; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN Vaccines & Prevention B.V., NL; |
| (54) | Title of the invention | Stabilized soluble pre-fusion rsv f protein for use in the prophylaxis of rsv infection |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 35/12 (2015.01.01); C07K 14/005 (2006.01.01); A61K 39/12 (2006.01.01) |
| (19) | Country | NL |
| (41) | Date of publication of the application | 2019.03.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.04.30 |
| (30) | Priority | 16163810, 2016.04.05, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2017/057962, 2017.04.04 |
| (87) | International publication | WO 2017/174568, 2017.10.12 |